CHAC1 and neoplasm: This loop’s clinical relevance was confirmed in vivo: in a CAF/PC-3 cell co-transplant mouse model, targeted silencing of miR-432-5p restored CHAC1 expression in tumor tissue by 3.2-fold (P<0.01) and enhanced DTX tumor suppression efficacy by 52% (44).